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Background: Variations in cytokine and immune mediator expression patterns in amniotic fluid due to gestational
age, maternal age and fetal gender were investigated.
Findings: Amniotic fluid samples were obtained from 192 women, 82 with a mid-trimester amniocentesis (median
gestational age 17 weeks) and 110 with a caesarean section not in labor (median gestational age 39 weeks).
Amniotic fluid was screened by commercial ELISAs for the TH1/TH2/TH17 cytokines and immune mediators IL-1
beta, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-15, IL-17, TNF alpha, GRO-alpha, MIP1alpha, MIP1beta, Histone, and IP10.
Analysis was by Bonferroni correction for multiple comparisons. None of the 15 examined cytokines revealed any
differences in expression patterns regarding fetal gender. Significant differences were found in IL-4, IL-10, IL-12,
TNF- alpha, GRO-alpha and MIP1-beta with respect to gestational age and in GRO-alpha regarding maternal age.
Conclusion: Cytokines utilized as biomarkers in the diagnosis of intrauterine infections are not influenced in their
expression pattern by fetal gender but may vary with respect to maternal age and gestational age.
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The diagnosis early in gestation of pregnancy complications
such as infection/inflammation, preeclampsia and intra-
uterine growth restriction would allow the maximum time
for initiation of treatment and monitoring. Clinical mani-
festations of disease often appear too late to allow for
meaningful intervention. Commonly used parameters, such
as measurement of C-reactive protein (CRP), leukocyte
subsets and concentrations of pro-calcitonin are nonspeci-
fic and therefore unreliable [1,2]. In addition, obese women
demonstrate higher levels of CRP and tumor necrosis fac-
tor (TNF)-alpha when compared to patients with lower
body mass index (BMI) [3]. Furthermore, chorioamnionitis
(CAM) is a histological diagnosis obtained after delivery
and, therefore, is not a diagnostic tool.* Correspondence: tobias.weissenbacher@med.uni-muenchen.de
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distribution, and reproduction in any mediumMany studies have investigated utilizing amniotic fluid
samples to detect differences in analyte concentrations
as biomarkers for pathological gestations [4,5]. The find-
ings to date remain inconclusive. The measurement of
interleukin 6 (IL-6) in the amniotic fluid (AF) is cur-
rently a frequently reported method to diagnose an
intrauterine infection [6-8]. Other cytokines, especially
IL-8, have also been suggested to have value in the diag-
nosis of an intrauterine infection [6,9]. Recent studies in-
dicate that inter-individual differences in cytokine levels
might be due to numerous factors including BMI [3],
intrauterine growth restriction, parity [10] or maternal
or fetal pathologies. Elevated levels of IL-6, IL-8 and IL-
10 were described in patients with hyperechogenic bowel
[4] and reduced cytokine levels in amniotic fluid were
reported in patients with Down`s syndrome fetuses [5].
Furthermore, elevated IL-10 levels in amniotic fluid were
detected in small for gestational age pregnancies [10].
Ethnicity is another potential influencing factor on cyto-
kine levels [11]. Therefore, intraamniotic cytokine valuesCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Gestational weeks and neonatal outcome of the
examined groups with case numbers
Neonatal outcome n Amniocentesis Caesarian section
Gestational week 186 17 (15–31) 39 (30–42)
Birth weight in gram 135 3340 (1480–4060) 3170 (1210–4668)
Birth-pH 130 7.32 (7.10-7.50) 7.33 (7.13-7.44)
Birth-base excess 127 −3.0 (−10.2-2.0) −2.0 (−21.0-1.2)
APGAR min 1 135 9 (0–10) 9 (2–10)
APGAR min 5 135 10 (8–10) 10 (6–10)
APGAR min 10 135 10 (8–10) 10 (8–10)
Median and range (in brackets) for continuous variables, percentages and
number of patients (in brackets) for discrete variables.
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infection [12].
A shortcoming of many amniotic fluid immune medi-
ator studies is the paucity, absence or consistency of data
on intraamniotic variations with gestational or maternal
age or with fetal gender. Few cytokines have been inves-
tigated with respect to differences in gestational age.
Levels of IL-6, IL-1beta and tumor necrosis factor alpha
(TNF-alpha) have been reported in some investigations
to increase throughout gestation and are highest at term
[13,14]. Other studies could not detect TNF-alpha and
IL-1beta throughout normal pregnancies and reported
constant levels of IL-6 and IL-8 [15]. Investigations of
expression patterns of additional potential immune bio-
markers in amniotic fluid with respect to gestational age,
as well as studies relating immune mediator concentra-
tion to the age of the mother and sex of the fetus, have
not been reported.
In the present study, we investigated concentrations of
15 immune mediators [IL-2, IL-17, IL-4, IL-6, IL-8, IL-
10, IL-12, IL-15, growth regulated oncogen-alpha (GRO-
alpha), macrophage inflammatory protein (MIP1alpha),
MIP1beta, Histone, TNF -alpha, IL1beta, IP10] of the T-
helper (TH) TH1, TH2 and TH17 pathway in human
amniotic fluid with respect to gestational age, gender of
the fetus and age of the mother. Knowledge of baseline
concentrations of immune mediators in amniotic fluid
throughout pregnancy would improve our ability to
analyze variations in levels as a diagnostic tool.
Methods
Study design and population
Subjects were attending consultations in the Department
of Obstetrics and Gynecology in the University Hospital,
Munich between 2007 and 2010. All patients were inter-
viewed regarding complaints, antibiotic use and history
of sexually transmitted diseases and vaginal infections.
Patients were screened for abnormalities in fetal devel-
opment at the enrolment visit. The institutional review
board of the Ludwig-Maximilians-University Munich,
Germany, approved this study and all patients gave writ-
ten informed consent prior to collection of amniotic
fluid.
A total of 192 patients were included in this study and
subdivided into two groups: 1) Women at term not in
labor who received caesarean section (CS) [n = 110, me-
dian gestational age (mga) = 39 weeks], 2) patients who
received an amniocentesis (AC) because of advanced
maternal age, patient’s request or because of an
increased risk for aneuploidies due to sonographic aber-
rations in nuchal translucency or abnormal levels of
serum biochemical markers [n = 82, mga = 17 weeks]. All
patients delivered in our hospital and gave birth to
healthy infants with no signs of infection or abnormality.The number of patients, range of gestational age as well
as the median gestational weeks are listed in Table 1.
Sample collection
None of the patients who received a caesarean section
had a membrane rupture prior to surgery and sample
collection. Amniotic fluid was obtained during caesarean
section following uterotomy and amniotomy. Five ml
amniotic fluid were obtained with a sterile syringe. In
women undergoing amniocentesis, samples were
obtained transabdominally. As a standard procedure,
ultrasound was initially performed to evaluate the pos-
ition of the fetus, the amount of amniotic fluid and the
site of the placenta. A 20 G x 3.5 needle was used and
guided under sonographic monitoring into the amniotic
cavity. Amniotic fluid was first taken for further diagnos-
tic tests dependant on the indication of the invasive pro-
cedure. Afterwards, 5 ml amniotic fluid were removed
with a syringe and further processed as specified below.
Samples were transported immediately in a capped ster-
ile syringe to the laboratory, divided into 1 ml aliquots
and stored at −80 °C until analyzed. Samples were stored
for four month in average until measurement.
Measurement of cytokines
Immune mediators in the amniotic fluid were measured
utilizing commercially available enzyme linked immuno-
sorbent assay (ELISA) kits (R&D Systems, Minneapolis,
MN, USA). A standard curve was obtained in parallel to
each assay and results converted to pg/ml.
Statistical analysis
Data were summarized by adequate measures of location
and spread for continuous variables and by proportions
for discrete variables. Differences in the cytokines be-
tween gestational age (Table 2) and fetal gender (Table 3)
were each evaluated by Mann–Whitney U tests. Differ-
ences in cytokine expression with respect to the age of
the mother (Table 4) were assessed by the Kruskal-
Table 2 Indications for caesarian section (with total
number and percentage)
Indication for C.section n percentage
C.section in history 43 39.1%
Breech presentation 19 17.3%
Multiples 8 7.3%
Uterus surgery in history 5 4.5%
Whish of the patient 4 3.6%
Others 31 28.2%
Weissenbacher et al. BMC Research Notes 2012, 5:375 Page 3 of 7
http://www.biomedcentral.com/1756-0500/5/375Wallis test. Furthermore, we modelled the differences in
the cytokines between AC and CS adjusted for maternal
age and sex of the fetus by using linear regressions. By
analogy, we modelled the differences in the cytokines be-
tween week of gestation adjusted for maternal age and
sex of the fetus. For each regression model we used
complete cases. In order to satisfy the normality as-
sumption of the linear regression models, we trans-
formed each of the cytokines by taking the natural
logarithm. Graphically based residual analyses were per-
formed for checking the assumptions of each of the fit-
ted linear regression models. The impact of the
independent variables (AC vs. CS, gestational age, fetal
sex, age of the mother) on the cytokines is quantified by
corresponding regression coefficients β. Each regression
coefficient is tested by using the t-test (two-sided) with
n–k degrees of freedom where n denotes the sample size
and k the number of regression coefficients in the re-
gression model. As many cytokines were tested andTable 3 Cytokine and immune mediator concentrations (pg/m
trimester – univariate analysis
Mediator Median concentration in
pg/ml (range)
Second trimester
IL-2 (n = 66) 2.1 (1.8-4.6)
IL-4 (n = 182) 10.0 (2.6-12.3)
IL-6 (n = 156) 1141.5 (91.2-2823)
IL-8 (n = 185) 1035.1 (235.7-4295.8)
IL-10 (n = 161) 4.9 (2.2-26.6)
IL-12 (n = 161) 4.8 (2.7-10.9)
IL-15 (n = 173) 15.4 (2.4-32.9)
IL-17 (n = 66) 17.5 (4.6-42.4)
TNF- α (n = 161) 22.1 (2.7-68.7)
GRO- α (n = 184) 248.8 (11.6-7029.7)
Pro IL1-ß (n = 157) 20.3 (15.2-43.2)
Histone (n = 161) 0.15 (0.05-0.55)
IP-10 (n = 169) 1042.5 (574.4-2696.1)
MIP1-ß (n = 182) 116.1 (16.1-485.2)
MIP1- α (n = 186) 23.2 (13.8-153.2)modelled we had to correct the p-values for multiple
testing. For that purpose we used the procedure of
Bonferroni-Holm. However, for conventional purposes
we report the uncorrected p-values and compare them
to the corrected ones. Hence, a corrected p-value of
<0.05 was considered as statistically significant. All stat-
istical analyses were performed by using R (version
2.12.2) and SPSS (version 16.0).
Results
192 women were screened for cytokine concentrations,
110 from those who underwent a CS and 82 who had an
amniocentesis. Of the CS subjects, 104 received a pri-
mary caesarean section while 6 underwent a secondary
caesarean section due to fetal distress. None of these six
cases had rupture of membranes.
The number of cases differed within each cytokine due
to missing completed at random, causally because of
some cases being out of measuring range.
Gestational age
The gestational age in the CS-group ranged from 30 to
42 weeks (mga 39). Within the AC-group the gestational
age ranged between 15 and 31 weeks (mga 17.6)
(Table 1). Moreover, neonatal outcome with birth
weights, APGAR-scores, birth-pH and base excess is
demonstrated in Table 1. Table 2 demonstrates the indi-
cations for C. section.
No statistically significant difference was found be-



























IL-2 (n = 66) 0.4-7.5 (4.7) 0.8-9.1 (3.9) 0.537
IL-4 (n = 182) 1.2-21.5 (8.6) 0.8-21.9 (8.3) 0.600
IL-6 (n = 156) 237.3-21275.0 (904.2) 120.8 -15825 (662.0) 0.079
IL-8 (n = 185) 0-5362.5 (664.9) 0-17125 (600.8) 0.644
IL-10 (n = 161) 2.4-18.5 (5.8) 2.2-85.6 (6.5) 0.559
IL-12 (n = 161) 0.7-23.7 (5.6) 0-17.3 (6.1) 0.478
IL-15 (n = 173) 2.5-169.4 (16.3) 2.4-165.8 (27.7) 0.868
IL-17 (n = 66) 3.5-47.9 (23.1) 4.1-39.7 (23.2) 0.940
TNF- α (n = 161) 5.3-30.3 (11.3) 2.9-659 (11.1) 0.870
GRO- α (n = 184) 14.5-7658.8 (1021.9) 12.3-6106 (1079.9) 0.985
Pro IL1-ß (n = 157) 0-269.1 (16.9) 2-1048.8 (18.1) 0.797
Histone (n = 161) 0.04-3.7 (0.2) 0.06-78.4 (0.3) 0.654
IP-10 (n = 169) 11.6-6781.6 (678.3) 0.4-32370 (703.6) 0.914
MIP1-ß (n = 182) 10.5-188.3 (25.4) 5.8-16305.8 (25.4) 0.590
MIP1- α (n = 186) 7.9-86.3 (26.1) 0-1531.3 (25.4) 0.410
Weissenbacher et al. BMC Research Notes 2012, 5:375 Page 4 of 7
http://www.biomedcentral.com/1756-0500/5/375of IL-2, IL-17, IL-6, IL-8, IL-15, MIP1 alpha, Histone,
GRO-alpha, ProIL-1beta or IP10. In the univariate ana-
lysis, IL-4, TNF-alpha, GRO-alpha and MIP1-beta
demonstrated significantly elevated levels in the second
trimester (AC-group) compared to the third trimester
(CS-group) with p = 0.022, p = 0.001, p = 0.003 andTable 5 Cytokine and immune mediator concentrations in
amniotic fluid by maternal age
Mediator Age Age Age Age Age p-
value19-25 26-30 31-35 36-40 >40
IL-2 (n = 66) 5.2 4.6 4.3 3.8 3.9 0.97
IL-4 (n = 182) 8.3 6.6 9.0 9.2 9.7 0.18
IL-6 (n = 156) 879.2 668.9 738.7 669.2 832.8 0.97
IL-8 (n = 185) 829.5 551.4 754 621.0 552.1 0.45
IL-10 (n = 161) 9.1 7.1 5.8 5.5 5.1 0.49
IL-12 (n = 161) 5.1 5.8 4.9 5.3 5.5 0.94
IL-15 (n = 173) 35.8 31.3 28.0 12.3 11.5 0.51
IL-17 (n = 66) 32.7 19.3 19.2 23.4 21.8 0.46
TNF- α (n = 161) 9.3 11.0 12.1 13.0 12.1 0.56
GRO- α (n = 184) 629.5 1254.3 1228.1 663.0 492.9 0.01
Pro IL1-ß (n = 157) 19.8 19.5 16.9 19.4 17.0 0.48
Histone (n = 161) 0.3 0.2 0.3 0.3 0.3 0.83
IP-10 (n = 169) 1435.3 644.6 722.7 814.0 702.8 0.33
MIP1-ß (n = 182) 27.5 25.8 28.3 25.9 27.7 0.71
MIP1- α (n = 186) 25.6 25.9 25.7 24.8 26.0 0.79
Median biomarker concentration (pg/ml) by maternal age.p = 0.001 respectively (Table 3). IL-10 and IL-12-levels
were significantly lower in the second trimester when
comparing to the third trimester (p = 0.037 and
p = 0.038) (Table3).
Gender of the fetus
82 samples were collected in the amniocentesis group.
We found a distribution of 31% boys and 69% girls. In
the group with caesarean section, 59 boys (53.6%) and
51 girls (46.4%) were evaluated. Univariate analysis
revealed no statistically significant differences between
fetal gender with regard to expression of any of the cyto-
kines (Table 4).
Maternal age
Maternal age ranged from 19.3 to 48.6 years in the
total sample. In the amniocentesis group the range
was 19.3 to 45.6 years (median age 36.5 years); in the
group with caesarean section maternal age ranged
from 22.5 to 48.5 years (median age 34.47 years).
GRO- alpha demonstrated higher levels in patients
who were 26–30 years and 31–35 years compared to
the other age groups (p = 0.01). None of the other 14
examined cytokines and chemokines revealed any dif-
ferences in expression patterns with regard to maternal
age (Table 5).
Discussion
The identification of specific immune mediators and
their concentration in amniotic fluid is receiving
Weissenbacher et al. BMC Research Notes 2012, 5:375 Page 5 of 7
http://www.biomedcentral.com/1756-0500/5/375increasingly attention as potential aids for making
informed diagnostic and therapeutic decisions. This field
remains unsettled, however, due to a lack of consistency
between observations in different investigations as well
as a scarcity of longitudinal data.
The composition of amniotic fluid changes during
pregnancy which was investigated by Unerwood et al
[16]. Accordingly, AF changes its milieu during preg-
nancy and is influenced by various factors such as gesta-
tional week, uterine perfusion and many more.
Especially in the second half of pregnancy AF compos-
ition seems to change [17].
Factors influencing cytokine expression patterns were
examined in the past and numerous variables such as
ethnicity, fetal diseases, small for gestational age preg-
nancies and body mass index were described [4,5,11].
Especially differences in cytokine expression patterns
regarding ethnicity were already described in literature
[11,18-21] and available data seem to be more consistent
when comparing to available data regarding fetal gender
or gestational week. Data are missing concerning var-
ieties of cytokine levels due to gestational week, fetal
gender or mothers` age and only few cytokines have
been reported with respect to these factors recently.
Bamberg et al investigated IL-6, IL-8 and TNF-alpha
in midtrimester amniotic fluid in pregnancies with nor-
mal outcome. The cytokine concentrations in this study
were correlated with gestational week, fetal gender and
parity [22]. In this study AC was performed between
15 + 0 and 20 + 6 weeks of gestation. Accordingly, no
correlation of cytokine levels with parity or fetal gender
could be found which underlines our results in these
three cytokines. Moreover, we found also no correlation
between fetal gender and mothers` age when looking at
the cytokines IL-1 beta, IL-2, IL-4, IL-12, IL-15, IL-17,
MIP1alpha, MIP1beta, Histone, and IP10. Regarding
gestational week, the authors found TNF-alpha values
differing between the 15th and 16th and the 15th and 18th
week.
Our results concerning TNF-alpha are consistent as
we demonstrated elevated TNF-alpha levels related to
gestational age. We investigated however further twelve
cytokines and demonstrated also elevated IL-4, TNF-
alpha, GRO-alpha and MIP 1-beta levels and lower IL-
10 and IL-12 levels with regard to gestational week.
Consistent data that investigated cytokine levels in amni-
otic fluid throughout pregnancy cannot be found in the
literature.
Chow et al. investigated differences in cytokine expres-
sion according to maternal age and fetal gender. IL-1ra
levels were demonstrated to increase with maternal age.
The fetal gender had an influence on IL-5 levels which
were higher in amniotic fluid of male fetuses [23]. We
did not look for IL-5 and IL-1ra in our study andtherefore were not able to compare our results on this
point. However, the cytokines IL-12, IL-15, IL-17, MIP-
alpha, MIP-beta and TNF-alpha were investigated in
Chow`s and in our study and no differences were found
in respect to maternal age and fetal gender which under-
lines our findings concerning these cytokines.
Contrasting, Bry et al found IL-1ra correlating to fetal
gender with higher amniotic fluid concentrations in fe-
male fetuses. Length of gestation did not affect the IL-
1ra levels [24]. Similar results were published by Romero
with a significant effect of fetal gender related to IL-1ra
levels [25]. As opposed to this IL-6 and IL-10 was inves-
tigated in midtrimester amniotic fluid by Poggi et al. and
the authors found fetal gender not affecting the IL-6 and
IL-10 levels in amniotic fluid. However the authors add-
itionally investigated angiogenin and demonstrated lower
angiogenin levels in amniotic fluid of male fetuses [26].
So according to the available literature data remain
inconsistent.
IL-5 and IL-1ra seem to be influenced by fetal gender,
whereas other cytokines are unaffected. Compared to
other studies, we investigated cytokines that were not
investigated so far relating to fetal gender, gestational
week and mothers’ age. At least IL-6, IL-8, IL-10 and
TNF-alpha that were already described in the literature
seem not to be affected by fetal gender, which we could
underline and differing to previous studies demonstrate
IL-1 beta, IL-2, IL-4, IL-12, IL-15, IL-17, GROalpha,
MIP1alpha, MIP1beta, Histone, and IP10 also not being
influenced by fetal gender.
A lack of consistency also exists between studies that
investigate individual cytokine expression with respect to
gestational age.
IL-2 was found to be different between 16th – 18th
week and term pregnancies [27]. In other studies IL-1,
IL-2, IL-6 and TNF-alpha seem to increase towards term
[28] [13]. The gestational age was not equally distributed
in these studies as well as in our study while the early
third trimester weeks are underrepresented. As regular
amniocentesis represents an invasive procedure during
pregnancy, it is most likely that is would not be
approved for research by any ethical committee. There-
fore the detection of cytokine levels dependant on gesta-
tional age is not investigated prospectively and
consistently so far. However, we investigated within a
wide range of gestational age (15th – 41th week) and
found elevated IL-4, TNF- alpha, GRO-alpha and MIP1-
beta levels and decreased levels of IL-10 and IL-12 in
the second trimester compared to the third trimester.
Data influencing cytokine expression by mothers’ age,
fetal gender and gestational age are inconsistent and lon-
gitudinal data are missing. When looking at published
studies, especially IL-1ra seems to be influenced by fetal
gender.
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In our study none of the investigated cytokines were
influenced by fetal gender or mothers’ age. It appears ob-
vious, however, that some cytokines in amniotic fluid
vary in concentration by gestational week. This needs to
be taken into account, when using these biomarkers as a
diagnostic tool. Furthermore, gestational age should be
considered when interpreting cytokine levels in amniotic
fluid and evaluating the clinical utility of measuring am-
niotic fluid cytokines.
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